Health and Healthcare

Amgen : AMGN

All Amgen Articles

704 Articles

Chris Lange | Jan 3, 2019 at 1:25 PM EST

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical shares made a handy gain on Thursday after it was announced that the firm has settled with Amgen…

Chris Lange | Dec 27, 2018 at 8:25 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The December 14 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Dec 12, 2018 at 8:40 AM EST

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

The November 30 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 28, 2018 at 8:20 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The November 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Nov 12, 2018 at 8:50 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 25, 2018 at 8:20 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The October 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Oct 10, 2018 at 8:20 AM EDT

Short Sellers Back Off Major Biotechs

The September 28 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Oct 1, 2018 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

The top analyst upgrades, downgrades and initiations seen on Monday included Amgen, Chipotle Mexican Grill, Lam Research, Netgear, Teva Pharmaceutical…

Lee Jackson | Sep 27, 2018 at 8:35 AM EDT

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term,…

Chris Lange | Sep 26, 2018 at 8:15 AM EDT

Major Biotechs Have Short Sellers on the Run

The September 14 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Sep 13, 2018 at 8:20 AM EDT

Short Sellers Up the Ante in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data…

Chris Lange | Aug 27, 2018 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Aug 15, 2018 at 11:50 AM EDT

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors.…

Chris Lange | Aug 10, 2018 at 8:45 AM EDT

Why Have Short Sellers Backed Off Major Biotechs?

The July 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Jul 30, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Ally, Amgen, AT&T, BP, Chesapeake Energy, Expedia, NOV, Square, Synchrony, Twitter and More

The top analyst upgrades, downgrades and other research calls from Monday includes Ally Financial, Amgen, AT&T, BP, Chesapeake Energy, Expedia,…

1 … 14 15 16 17 18 … 47

Amgen : AMGN

All Amgen Articles

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Short Sellers Hike Their Bets in Major Biotechs

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Major Biotechs Have Short Sellers on the Run

Short Sellers Up the Ante in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Why Have Short Sellers Backed Off Major Biotechs?

Top Analyst Upgrades and Downgrades: Ally, Amgen, AT&T, BP, Chesapeake Energy, Expedia, NOV, Square, Synchrony, Twitter and More

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here’s How to Claim 30% Back

Ethereum Rallied 8% This Month While XRP Fell. Which Is the Better Buy?

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here's How to Claim 30% Back

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here’s How to Claim 30% Back

Amgen : AMGN

All Amgen Articles

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Still Can’t Make Up Their Mind on Major Biotech Stocks

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Raise the Stakes in Major Biotechs

Short Sellers Hike Their Bets in Major Biotechs

Short Sellers Back Off Major Biotechs

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now

Major Biotechs Have Short Sellers on the Run

Short Sellers Up the Ante in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

Why Have Short Sellers Backed Off Major Biotechs?

Top Analyst Upgrades and Downgrades: Ally, Amgen, AT&T, BP, Chesapeake Energy, Expedia, NOV, Square, Synchrony, Twitter and More

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here’s How to Claim 30% Back

Ethereum Rallied 8% This Month While XRP Fell. Which Is the Better Buy?

Featured Reads

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Your Solar Tax Credit Expires December 31, 2025, but Here's How to Claim 30% Back